Cellular‐mesenchymal to epithelial transition factor (c‐MET), a known oncogene that promotes cancer progression in various cancers, has been shown to be a direct target of miR‐144‐3p in MM.26 This evidence concerns the gene MET and Miyoshi myopathy.